Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Bio Farma Urges OIC Countries to Strengthen Vaccine Cooperation

Published: Monday, June 17, 2013
Last Updated: Monday, June 17, 2013
Bookmark and Share
Bio Farma to make OIC Countries self-reliance in vaccine industry.

Bio Farma has urged Organization of Islamic Cooperation (OIC) member countries to strengthen cooperation in vaccine research to make them self-reliance in vaccine industry.

"We need to strengthen our collaboration in research, production and supply of biological products related to vaccine," Bio Farma President Director Iskandar (one name) said in his presentation in front of vaccine experts attending the 2nd meeting of OIC vaccine & medicine manufacturers, in Bandung, on Sunday.

Prior to Iskandar's presentation on OIC vaccine industry cooperation, delegates from nine OIC member countries (which already have vaccine-making companies or institutions) had approved appointment of Juliman (one name), Bio Farma Director of Production, as chair of the meeting that runs from 16 to 19 June, 2013.

Iskandar emphasized the importance of vaccine research and production among OIC member countries to make them self-reliant in vaccine industry.

He noted the experience of Indonesia, being the world's largest Moslem nation with a population of 240 million, whose need of vaccine has been supplied by the 123-year-old Bio Farma.

For the shorter term period, he said Bio Farma wishes to strengthen the cooperation among Islamic countries in vaccine production while for the medium term it wants to jointly develop new vaccines which are needed by Islamic countries.

Delegates attending the meeting enthusiastically welcomed Indonesia's ideas for an increased cooperation in vaccine research and production to make them self-reliant in vaccine supplies for meeting their needs of vaccine.

Iran and Saudi Arabia, especially, had appreciated Bio Farma's offer for cooperation and initiative on vaccine self-reliance among Islamic countries.

Indonesia's decision to host the meeting is a follow up to the decision of the meeting of Islamic Countries' Advisory Group in Ankara Turkey and the 6th meeting of the OIC Steering Committee on Health in Jakarta.

In addition, the Indonesian government through the letter of the Secretary General of the Ministry of Health to OIC Secretary General has also expressed willingness to host a meeting to finalize the implementation plan for Strategic Health Action Programme 2013-2022.

Bio Farma itself is Indonesia's only vaccine manufacturer whose some of its products have been recognized by the World Health Organization (WHO) so that the company can supply its products to over 100 countries worldwide.

Currently the needs for Expanded Program on Immunization (EPI) vaccines in Indonesia have been supplied solely by Bio Farma by producing and distributing over 1.7 billion doses of vaccine per year to meet the needs of EPI vaccine for national immunization program.

Bio Farma has an outstanding international reputation based on the WHO prequalification for all of its EPI vaccine products. It has also implemented green industry and is environment friendly.

WHO acknowledges that Bio Farma vaccine products are of high quality, efficacious, and affordable.

Bio Farma products are exported to countries around the world through the direct distribution or through various agencies such as UNICEF and PAHO.

The company has obtained the Best Export Performance from the Indonesian Trade Ministry consecutively in 2010, 2011 and 2012 as an evidence of its consistent exceptional performance.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Bio Farma Offers Partnerships in Vaccine Development
Company to partner with vaccine manufacturers in developing and Islamic countries.
Monday, October 29, 2012
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos